Medicinal Products

Palexia retard 150 mg tablete s produljenim oslobađanjem

Name Palexia retard 150 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-687263718
Active Substance tapentadolklorid
Composition jedna tableta s produljenim oslobađanjem sadrži 150 mg tapentadola (u obliku tapentadolklorida)
Pharmaceutical Form tableta s produljenim oslobađanjem
Manufacturer Grünenthal GmbH, Aachen, Njemačka
Marketing Authorisation Holder Grünenthal GmbH, Zieglerstraße 6, Aachen, Njemačka
Marketing Authorisation Date 27.07.2015
MA Period of Validity unlimited
Classification Number UP/I-530-09/14-02/426
Registration Number 381-12-01/30-15-07
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to special medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N02AX06
Marketing status Marketed
Shortage status No shortage
SmPC download
PL download
Public Assessment Report download

Packaging

Back

For Patients and Public

For Health Care Professionals

For Industry Representatives